Reported side effects in human anecdotal use are generally mild and may include: Mild nausea, particularly with oral administration Redness, itching, or irritation at the injection site Temporary dizziness or mild headache Changes in appetite or weight A significant theoretical concern revolves around its pro-angiogenic properties
Cagrilintide Phase 2 monotherapy (Lau et al., Lancet 2021) reported about 10.8% weight loss at 26 weeks at 4.5 mg
In addition, certain medications can reduce the absorption (and therefore the benefits) associated with B12
potentially enhancing skin moisture, elasticity, and reduce wrinkles for a more youthful appearance
Always consult a licensed healthcare professional before considering any peptide or supplement
For some, that will mean an injection session every year or two but for others, it will mean more frequency and consistency